期刊文献+

不同周龄SD雄性大鼠2型糖尿病建模初步探讨 被引量:2

Preliminary investigation on the establishment of Sprague Daw ley male rat model with type 2 diabetes of different ages
下载PDF
导出
摘要 目的探讨不同周龄SD雄性大鼠对2型糖尿病建模成功率的影响,并分析SD雄性大鼠2型糖尿病建模的最佳时间。方法 6周龄和8周龄的SD雄性大鼠两组,普通饲料喂养,分别同时进行为期6周的高糖高脂饲养,给予30mg/kg剂量的链脲佐菌素于腹腔注射,3d后观察建模成功率(成模率);未成模的SD大鼠第2次注射同剂量的链脲佐菌素。结果 6周龄组的SD大鼠建模成功率(65.5%)比8周龄组(93.1%)低,血糖比较差异有统计学意义(P<0.01),第2次注射后6周龄组SD大鼠建模成功率(29.4%)比8周龄组(83.3%)低。结论 8周龄的SD雄性大鼠高糖高脂饲料饲养6周再结合30mg/kg剂量的链脲佐菌素是成功的2型糖尿病大鼠模型;SD雄性大鼠周龄是影响建模成功的重要因素之一。 Objective To explore the effect of different ages on the success rate of Sprague Daw ley (SD) male rat model of type 2 diabetes, and to analyze the best time for developing SD male rat model of type 2 diabetes. Methods The 6-week-old male SD rats (group A) and the 8-week-old male SD rats (group B) were selected to estab- lish SD male rat models of type 2 diabetes. The rats were fed with high-fat diet for 6 weeks, and then injected intraperi- toneally with STZ (30 mg/kg). After 3 days, the success rate of establishing model was observed. Unsuccessful model rats were injected with the same dose of STZ. Results The success rate (65.5%) of group A was significantly lower than that of group B (93.1%), with statistically significant difference in blood sugar between two groups (P〈0.01). The success rate of the 24 injection was significantly lower in group A (29.4%) than group B (83.3%). Conclusion SD male rat models of type 2 diabetes can be established successfully by feeding the 8-week-old male SD rats with high fat and sugar diet for 6 weeks and injecting 30 mg/kg dose streptozotocin. The age is one of the important factors that affect the success rate of establishing SD male rat models of type 2 diabetes.
出处 《海南医学》 CAS 2013年第10期1408-1410,共3页 Hainan Medical Journal
关键词 SD大鼠 2型糖尿病 成功率 SD rats Type 2 diabetes Success rate
  • 相关文献

参考文献9

二级参考文献43

共引文献136

同被引文献35

  • 1雷作熹,罗仁,董晓蕾,钟先阳.STZ诱导糖尿病肾病大鼠模型的建立[J].中国实验动物学报,2005,13(3):163-165. 被引量:82
  • 2李伟,张红,殷松楼,褚璇.不同剂量链脲佐菌素诱导SD大鼠糖尿病肾病模型的研究[J].徐州医学院学报,2006,26(1):52-55. 被引量:55
  • 3徐颖,周世文,汤建林,黄永平,陈莎.实验性糖尿病肾病大鼠模型建立及优化[J].第三军医大学学报,2006,28(22):2247-2249. 被引量:29
  • 4Yamagishi S, Fukami K, Ueda S, et al. Molecular mecha- nisms of diabetic nephropathy and its therapeutic interven- tion[J]. Curr Drug Targets,2007,8(8) : 952.
  • 5Goh S Y, Cooper M E. Clinical review: The role of ad- vanced glycation end products in progression and complica- tions of diabetes [ J ]. J Clin Endocrinol Metab, 2008 93 (4) :1143.
  • 6Cumbie B C, Hermayer K L. Current concepts in targeted therapies for the pathophysiology of diabetic mierovaseular complications [J].Vase Health Risk Manag, 2007,3 ( 6 ) : 823.
  • 7Gnudi L,Viberti G, Raij L, et al. GLUT - 1 overexpres- sion: Link between hemodynamie and metabolic factors in glomerular i nj ury [ J ]. Hypertension, 2003,42 ( 1 ) : 19.
  • 8Attman P O, Knight - Gibson C, Tavella M, et al. The com- positional abnormalities of lipoproteins in diabetic renal failure[ J]. Nephrol Dial Transplant, 1998, 13 ( ll ) : 2833.
  • 9Saito T. Abnormal lipid metabolism and renal disorders [J]. Tohoka J Exp Med,1997,181 (3) :321.
  • 10Chen H C, Guh J Y, Chang J M, et al. Role of lipid control in diabetic nephropathy [ J ]. Kidney Int Suppl, 2005 ( 94 ) : $60.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部